Pinpoint drug delivery system using hollow bio-nanoparticles

Tadanori Yamada, Masaharu Seno, Akihiko Kondo, Masakazu Ueda, Katsuyuki Tanizawa, Shun'ichi Kuroda

Research output: Contribution to journalArticle

Abstract

Hepatitis B virus envelope L proteins produced in yeast cells form hollow nanoparticles (L particles, average diameter 220 nm) displaying human liver-specific receptor. Recently, the L particles were found to incorporate genes, proteins, and drugs, and act as an efficient pinpoint delivery system to human liver-derived tissues in xenograft models. By substituting the epidermal growth factor (EGF) for human liver-specific receptor, the mutated L particles showed the affinity to the EGF receptor, not to human liver. Other similar HBV envelope proteins, e.g., M and S particles, have already been commercialized for hepatitis B vaccine, strongly suggesting the safety of L particles in human. These results indicate that the hollow bio-nanoparticles are a promising candidate for the next-generation platform of DDS, especially that related to gene therapy.

Original languageEnglish
Pages (from-to)606-612
Number of pages7
JournalKOBUNSHI RONBUNSHU
Volume61
Issue number12
DOIs
Publication statusPublished - Dec 2004

Keywords

  • Drug delivery system
  • Gene therapy
  • Hemophilia
  • Hepatitis B virus
  • In vivo
  • Nanoparticle
  • Retargeting
  • Yeast

ASJC Scopus subject areas

  • Chemical Engineering (miscellaneous)
  • Materials Science (miscellaneous)
  • Environmental Science(all)
  • Polymers and Plastics

Fingerprint Dive into the research topics of 'Pinpoint drug delivery system using hollow bio-nanoparticles'. Together they form a unique fingerprint.

  • Cite this

    Yamada, T., Seno, M., Kondo, A., Ueda, M., Tanizawa, K., & Kuroda, S. (2004). Pinpoint drug delivery system using hollow bio-nanoparticles. KOBUNSHI RONBUNSHU, 61(12), 606-612. https://doi.org/10.1295/koron.61.606